Sydenham's chorea-clinical characteristics of nine patients
- PMID: 15301906
- DOI: 10.1016/j.ijcard.2003.05.039
Sydenham's chorea-clinical characteristics of nine patients
Abstract
Sydenham's chorea is still the most frequently seen form of acquired chorea in childhood in developing countries. Nine patients presented with Sydenham's chorea as one of the major criteria (one or more attacks) were evaluated their clinical characteristics and treatment. All patient were given sodium valproate. Clinical improvement began 11+/-4.0 days in sodium valproate treatment, and no adverse effect was seen due to the drugs. Echocardiography revealed rheumatic carditis sequela in all patient. The nine Sydenham's chorea patients presented 13 attacks of chorea in follow-up. We observed isolated chorea in 44% of patients, and 22% presented one or more recurrences. The interval between the attacks ranged from months to 2 years. The 90% of the patients were not on prophylaxis with benzathine penicillin. One patient had diagnosis of obsessive-compulsive disorder, and one had diagnosis of attention deficit hyperactivity disorder in the follow-up period. This report emphasizes the significance of Sydenham's chorea and sequela of rheumatic carditis association and a high risk of developing neuropsychiatric disorders in the follow-up period. Valproic acid is an effective and safe drug in the treatment of Sydenham's chorea.
Similar articles
-
Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review.J Clin Psychiatry. 1996 Sep;57(9):407-14. J Clin Psychiatry. 1996. PMID: 9746449 Review.
-
[Acute rheumatic fever, Sydenham's chorea and psychopathology].Turk Psikiyatri Derg. 2002 Summer;13(2):137-41. Turk Psikiyatri Derg. 2002. PMID: 12794666 Turkish.
-
The prevalence of neuropsychiatric disorders in Sydenham's chorea.Pediatr Neurol. 2010 Apr;42(4):243-8. doi: 10.1016/j.pediatrneurol.2009.12.004. Pediatr Neurol. 2010. PMID: 20304326
-
Sydenham's chorea, and its complications affecting the nervous system.Brain Dev. 2009 Jan;31(1):11-4. doi: 10.1016/j.braindev.2008.05.001. Epub 2008 Jun 16. Brain Dev. 2009. PMID: 18558468 Review.
-
Sydenham's chorea: a clinical follow-up of 65 patients.J Child Neurol. 2007 May;22(5):550-4. doi: 10.1177/0883073807302614. J Child Neurol. 2007. PMID: 17690060 Clinical Trial.
Cited by
-
Neuropsychological manifestations in children with Sydenham's chorea after adjunct intravenous immunoglobulin and standard treatment.Metab Brain Dis. 2016 Feb;31(1):205-12. doi: 10.1007/s11011-015-9681-1. Epub 2015 May 19. Metab Brain Dis. 2016. PMID: 25987537
-
Sodium valproate in the treatment of Sydenham's chorea.Indian J Pediatr. 2010 Jun;77(6):703. doi: 10.1007/s12098-010-0074-5. Indian J Pediatr. 2010. PMID: 20454934 No abstract available.
-
An update on the treatment of Sydenham's chorea: the evidence for established and evolving interventions.Ther Adv Neurol Disord. 2010 Sep;3(5):301-9. doi: 10.1177/1756285610382063. Ther Adv Neurol Disord. 2010. PMID: 21179620 Free PMC article.
-
Treatment of Sydenham's Chorea: A Review of the Current Evidence.Tremor Other Hyperkinet Mov (N Y). 2017 Jun 1;7:456. doi: 10.7916/D8W95GJ2. eCollection 2017. Tremor Other Hyperkinet Mov (N Y). 2017. PMID: 28589057 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources